SCHEMBL5230843

SCHEMBL5230843

Cc1cccc(-c2nn3cc(-c4ccccc4)ccc3c2Br)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.40
MEN1 O00255 2/20 0.40
USP2 O75604 2/20 0.40
KMT2A Q03164 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MAPK1 P28482 1/20 0.40
ATM Q13315 1/20 0.40
TGFBR1 P36897 12/20 0.40
MAPK14 Q16539 2/20 0.40
CCR1 P32246 1/20 0.38
CCR8 P51685 1/20 0.38
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
HSD17B10 Q99714 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
THRB P10828 2/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23389936 0.82 CCR1 (0.40) TGFBR1MAPK14CCR1CCR8THRB
SCHEMBL29796504 0.82 CCR1 (0.40) TGFBR1MAPK14CCR1CCR8THRB
SCHEMBL5229013 0.81 TGFBR1 (0.42) KDM4EMEN1USP2KMT2AL3MBTL1
SCHEMBL4874607 0.81 TGFBR1 (0.52) TGFBR1MAPK14THRB
SCHEMBL4868073 0.80 TGFBR1 (0.43) TGFBR1MAPK14CCR1CCR8THRB
SCHEMBL5232936 0.78 PTGS2 (0.46) TGFBR1MAPK14CCR1CCR8THRB
SCHEMBL5232777 0.76 TGFBR1 (0.46) KDM4EMEN1KMT2AL3MBTL1TGFBR1
SCHEMBL5235703 0.73 TGFBR1 (0.41) TGFBR1MAPK14CCR1CCR8THRB
SCHEMBL2189142 0.70 KMT2A (0.62) KDM4EMEN1KMT2AL3MBTL1ATM
SCHEMBL4873701 0.69 AKT1 (0.46) MAPK1TGFBR1MAPK14CCR1CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1543001-B1 PYRAZOLOPYRIDINE DERIVATIVES AS TGF BETA SIGNAL TRANSDUCTION INHIBITORS FOR THE TREATMENT OF CANCER LILLY CO ELI (US) 2007-08-15 EP disclosed